Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-22 @ 6:48 AM
Study NCT ID:
NCT01756404
Status:
COMPLETED
Last Update Posted:
2018-12-13
First Post:
2012-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2007-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-20
First Submit QC Date:
None
Study First Post Date:
2012-12-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-11
Last Update Post Date:
2018-12-13
Last Update Post Date Type:
ACTUAL